FGFR1 (FLT2 or CD331) Antibody - FFPE Validated

Biological Background

Build reproducible readouts by using this antibody to assess FGFR1 (FLT2) across matched sample sets. FGFR1 is a regulator within kinase-driven cascades that influence transcriptional and metabolic responses. Use matched handling so differences reflect biology rather than processing.

In some datasets and protocols, it is referenced by the gene symbol FLT2.

Use in the Laboratory

Signaling targets are typically assessed across time courses to capture transient activation windows. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

• time-resolved changes following stimulation or inhibition
• localization shifts between cytoplasm, membrane, and nucleus
• interaction patterns within multi-protein complexes
• condition-to-condition comparisons with matched controls

Version Notes

Because fixation can mask epitopes, fixed-section oriented formats aim to maintain recognition after standard deparaffinization and retrieval steps. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. A brief pilot run can help set exposure ranges and reduce reruns later.

For challenging targets, pairing FGFR1 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

With consistent handling, the fixed-section format can make FGFR1 (FLT2) comparisons easier to reproduce across runs.